Module 12: Marijuana, Hallucinogens, Inhalants, and Steroids

Module 12: References

Freisthler, B., Ponicki, W.R., Gaidus, A., & Gruenewald, P.J. (2016). A micro-temporal geospatial analysis of medical marijuana dispensaries and crime in Long Beach, California. Addiction, 111, 1027-1035.

National Institute on Drug Abuse (NIDA). (2015). Hallucinogens and Dissociative Drugs
Research Report. Retrieved from https://www.drugabuse.gov/publications/research-reports/hallucinogens-dissociative-drugs/director

National Institute on Drug Abuse (NIDA). (2016). MDMA (Ecstasy, Molly). Retrieved from https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly

National Institute on Drug Abuse (NIDA). (2017). Marijuana. Retrieved from https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/1380-marijuana.pdf

National Institute on Drug Abuse (NIDA). 2017 Drug Facts series, Inhalants. Retrieved from https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/df_inhalants_feb2017.pdf

National Institute on Drug Abuse (NIDA). (2016), Drug Facts about Anabolic Steroids. Retrieved from https://www.drugabuse.gov/publications/drugfacts/anabolic-steroids

Substance Abuse and Mental Health Services Administration (SAMHSA). (2016). Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUH-FFR1-2015/NSDUH-FFR1-2015.htm

License

Icon for the Creative Commons Attribution-NonCommercial 4.0 International License

Module 12: References by Audrey Begun is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, except where otherwise noted.

Share This Book